A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma
NCT05432219 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-06-27
Summary
This is a a prospective, single-arm, and exploratory study of endoscopic resection of recurrent nasopharyngeal carcinoma via transoral retropterygoid approach.
Conditions
- Recurrent Nasopharyngeal Carcinoma
Interventions
- PROCEDURE
-
endoscopic surgery
endoscopic resection of recurrent nasopharyngeal carcinoma via the transoral retropterygoid nasopharyngectomy approach
Sponsors & Collaborators
-
Chinese Academy of Medical Sciences
collaborator OTHER -
Eye & ENT Hospital of Fudan University
lead OTHER
Principal Investigators
-
Hongmeng Yu, MD,PhD · Eye&ENT Hospital, Fudan University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-30
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
More Related Trials
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma
NCT05341479 ·Status: UNKNOWN
-
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
NCT01164566 ·Status: TERMINATED ·Phase: NA
-
NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma
NCT04215471 ·Status: UNKNOWN ·Phase: PHASE2
-
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
NCT04481100 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
NCT02325986 ·Status: UNKNOWN ·Phase: PHASE2
-
Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
NCT05951127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radical Resection of Single-hole Inflatable Mediastinal Mirror Synchronization With Laparoscopic Esophageal Carcinoma
NCT03657914 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial of Esophagectomy for Esophageal Carcinoma
NCT06691503 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NCT05327517 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
NCT01089803 ·Status: COMPLETED
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT02355249 ·Status: UNKNOWN ·Phase: PHASE3
-
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
NCT04224389 ·Status: RECRUITING
-
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
NCT03927495 ·Status: UNKNOWN ·Phase: PHASE2
-
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
NCT03904927 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Esophagectomy in Complete Responders to CCRT
NCT01740375 ·Status: TERMINATED ·Phase: PHASE3
-
Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
NCT01086488 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
NCT02446574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
NCT05596890 ·Status: UNKNOWN ·Phase: PHASE2
-
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
NCT03428074 ·Status: COMPLETED
-
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
NCT00154804 ·Status: COMPLETED ·Phase: PHASE2
-
China Early Esophageal Cancer Cohort
NCT06515964 ·Status: RECRUITING
-
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 ·Status: RECRUITING ·Phase: NA